Illumina, Inc.

Illumina, Inc.
Company type	Public
Traded as	Nasdaq: ILMN; NASDAQ-100 component; S&P 500 component;
Industry	Biotechnology
Founded	1998
Founders	David Walt; Larry Bock; John Stuelpnagel; Anthony Czarnik; Mark Chee;
Headquarters	San Diego, California, U.S.
Key people	Jacob Thaysen; (CEO); Stephen P. MacMillan (Chairman);
Products	NovaSeq; HiSeq; MiSeq; MiniSeq; iSeq; NextSeq; iScan; COVIDSeq; VeriSeq; DRAGEN; Illumina Connected Analytics; TruSight Oncology;
Revenue	US$4.58 billion (2022)
Operating income	US$−4.2 billion (2022)
Net income	US$−4.4 billion (2022)
Total assets	US$12.3 billion (2022)
Total equity	US$6.60 billion (2022)
Number of employees	10,200 (Jan 2023)
Website	illumina.com
	Footnotes / references;

Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California, and it serves more than 155 countries. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets.

Illumina's customers include genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, and biotechnology companies.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.